This finding may be because when GM-CSF atomized inhalation was used, the drug was in higher concentration when it made oral contact with the mucous membrane than the gargle form, and the effect of the drug on oral mucositis is dose-dependent. The gene discussed is CSF2; the disease is oral mucositis.